Scientists at Johns Hopkins have uncovered a surprising new way to influence brain activity by targeting a long-mysterious class of proteins linked to anxiety, schizophrenia, and movement disorders.

IntraBio’s Aqneursa receives European Commission’s marketing approval for treatment of Niemann-Pick Type C disease: Austin, Texas Saturday, January 24, 2026, 14:00 Hrs [IST] I ...

Johns Hopkins researchers found that delta-type ionotropic glutamate receptors (GluDs) play a key role in regulating neuronal ...

The teenager needs access to treatment that's only available in Europe and comes at a cost of £300,000. | ITV News Granada ...

Koch, who studied vision, thought that by measuring people's brain responses as they looked at special optical illusions, ...

Scientists reveal the GluD brain protein's active role, offering new hope for mental health. Discover how this breakthrough ...

Alcohol and MS both affect the central nervous system. Short-term effects of drinking can include balance issues, fatigue, brain fog, and vision changes. Heavy drinking can impact overall health.

For a long time, the study of the brain has largely focused on neuronal cells. However, neurons develop and interact closely together in space and time with ...

IntraBio Inc. today announced positive topline results from its pivotal Phase III IB1001-303 clinical trial, "Effects of N-Acetyl-L-Leucine on Ataxia-Telangiectasia (A-T): A Randomized, ...

IntraBio Inc. today announced that the European Commission granted marketing authorization to AQNEURSA(levacetylleucine) for the treatment of neurological manifestations of Niemann-Pick Type C (NPC) ...